A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CFRD / CF-related diabetes

[Related PubMed/MEDLINE]
Total Number of Papers: 84
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CFRD  (>> Co-occurring Abbreviation)
Long Form:   CF-related diabetes
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Abnormal glucose tolerance and the 50-gram glucose challenge test in Cystic fibrosis. CF, GCT, OGTT
2020 Cystic fibrosis-related diabetes: an update on pathophysiology, diagnosis, and treatment. CF, CFTR
2020 Cystic fibrosis-related diabetes: The unmet need. CF
2020 Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries. CF
2020 Dyslipidemia is not associated with the development of glucose intolerance or diabetes in cystic fibrosis. CF
2020 Genetic Modifiers of Cystic Fibrosis-Related Diabetes Have Extensive Overlap With Type 2 Diabetes and Related Traits. CF, PRSs, T1D, T2D
2020 Increased expression of anion transporter SLC26A9 delays diabetes onset in cystic fibrosis. CF, CFTR, scRNA-seq
2020 Influence of Cystic Fibrosis-Related Diabetes on Mental Health in Adults: A Single-Center Study. CF
2020 Some young adults with cystic fibrosis-related diabetes may safely stop insulin without any adverse clinical sequelae. CF
10  2019 Effects of aerobic interval training on glucose tolerance in children and adolescents with cystic fibrosis: a randomized trial protocol. AIT, CF, CFDR
11  2019 Extra-respiratory comorbidities and transplantation in the French cystic fibrosis registry. CF, LT
12  2019 Glucose tolerance in Canadian and French cystic fibrosis adult patients. BMI, CF
13  2019 Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis. ALT, CF, NAFLD, OGTT
14  2019 Mutations in the HFE gene can be associated with increased lung disease severity in cystic fibrosis. CF, DIOS, MI
15  2019 Pre-transplant factors associated with mortality after lung transplantation in cystic fibrosis: A systematic review and meta-analysis. Bcc, BMI, CF, NOS
16  2019 Screening for cystic fibrosis-related diabetes and prediabetes: Evaluating 1,5-anhydroglucitol, fructosamine, glycated albumin, and hemoglobin A1c. 1,5-AG, 2hG, CF, FA, FEV1, FVC, GA, HbA1c, OGTT
17  2019 The main mechanism associated with progression of glucose intolerance in older patients with cystic fibrosis is insulin resistance and not reduced insulin secretion capacity. AGT, CF
18  2018 Prevalence of hypoglycemia during oral glucose tolerance testing in adults with cystic fibrosis and risk of developing cystic fibrosis-related diabetes. CF, OGTT, PG
19  2018 Relationship between exercise capacity and glucose tolerance in cystic fibrosis. AGT, EC, NGT, OGTT
20  2017 CFTR is involved in the regulation of glucagon secretion in human and rodent alpha cells. CF, CFTR
21  2017 Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis. ABPA, Af, CF, PA
22  2017 Estimating Direct Cost of Cystic Fibrosis Care Using Irish Registry Healthcare Resource Utilisation Data, 2008-2012. CF, CFTR, MRSA, ppFEV1
23  2016 Glucose Fluctuations are Not Modulated by the Proportion of Calories from Macronutrients or Spontaneous Total Energy Expenditure in Adults with Cystic Fibrosis. CF, TEE
24  2016 Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes. CF, OGTT
25  2016 How patients' representations of cystic fibrosis-related diabetes inform their health behaviours. CF
26  2016 Hyperglycaemia and Pseudomonas aeruginosa acidify cystic fibrosis airway surface liquid by elevating epithelial monocarboxylate transporter 2 dependent lactate-H+ secretion. ASL, CF, HBE, MCTs
27  2016 Screening for Cystic Fibrosis-Related Diabetes: Matching Pathophysiology and Addressing Current Challenges. CF, OGTT
28  2016 The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis. CF, OGTT
29  2016 Under Utilization of Pancreas Transplants in Cystic Fibrosis Recipients in the United Network Organ Sharing (UNOS) Data 1987-2014. CF, UNOS
30  2015 Disposition index identifies defective beta-cell function in cystic fibrosis subjects with normal glucose tolerance. CF, CON, DI, NGT, OGTT
31  2015 Elevation of one hour plasma glucose during oral glucose tolerance testing. CF
32  2015 Evidence for a Cystic Fibrosis Enteropathy. CF, EPI, I-FABP, PPI
33  2015 Insulin secretion abnormalities in exocrine pancreatic sufficient cystic fibrosis patients. CF, OGTT
34  2015 Management of endocrine disease: Cystic fibrosis-related diabetes: novel pathogenic insights opening new therapeutic avenues. CF, CFTR
35  2015 Overweight and obesity in patients with cystic fibrosis: a center-based analysis. CF, OSA
36  2015 The role of receptor for advanced glycation end products in airway inflammation in CF and CF related diabetes. AGE, CF, es, FL, RAGE
37  2014 Cystic fibrosis related diabetes--a new perspective on the optimal management of postprandial glycemia. CF, GIP, GLP-1, T2D
38  2014 Cystic fibrosis related diabetes: potential pitfalls in the transition from paediatric to adult care. ADA, CF, ISPAD
39  2014 Evidence for a causal relationship between early exocrine pancreatic disease and cystic fibrosis-related diabetes: a Mendelian randomization study. CF, CFTR, IRT
40  2014 Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry. BMI, CF, ECFSPR, FEV1
41  2014 Glucose-induced electrical activities and insulin secretion in pancreatic islet beta-cells are modulated by CFTR. CF, CFTR
42  2014 Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test. CF, IFG, IGT, NGT, OGTT, OR
43  2013 Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients. CF, FEV1, HR
44  2013 Diagnosis of cystic fibrosis-related glucose abnormalities: Can we shorten the standard oral glucose tolerance test? APCF, IGT, OGTT, ROC-AUC
45  2013 Genetic modifiers of cystic fibrosis-related diabetes. CF, CFTR, HR, SNPs
46  2013 Outcome of cystic fibrosis-related diabetes two years after lung transplantation. CF, LT
47  2013 Progression of structural lung disease on CT scans in children with cystic fibrosis related diabetes. CF, CT, IGT, NGT
48  2013 The impact of dysglycaemia on bone mineral accrual in young people with cystic fibrosis. BMC, BMD, FN, IGT, LS, NGT, TB, vBMD
49  2012 Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets. CF
50  2012 Cystic fibrosis: a clinician's tool for management of care advancing into the adult population. CF, CFF, CFLD
51  2012 Factors associated with a shorter time until the next pulmonary exacerbation in adult patients with cystic fibrosis. ABPA, CF, CRP, PA, TUNE
52  2012 Insulin production and resistance in cystic fibrosis: effect of age, disease activity, and genotype. AIR, CF, FGIR, FPIR, HOMA-IR, IGT
53  2012 Screening for cystic fibrosis-related diabetes: a systematic review. BG, CF
54  2012 Totally implantable central venous access ports in patients with cystic fibrosis: a multicenter prospective cohort study. CF, TIVAD
55  2012 [Abnormal glucose tolerance in prepubertal patients with cystic fibrosis]. AGT, CF, IGT, INDET, NGT, OGTT
56  2011 Risk factors for chronic kidney disease in adults with cystic fibrosis. CF, CI, HR
57  2010 Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system. CF, CGMS, IGT, OGTT
58  2010 Combined pancreatic islet-lung transplantation: a novel approach to the treatment of end-stage cystic fibrosis. CF
59  2010 MRI appearance of the pancreas in patients with cystic fibrosis: a comparison of pancreas volume in diabetic and non-diabetic patients. CF
60  2010 Natural history of glucose intolerance in patients with cystic fibrosis: ten-year prospective observation program. CF, FH, IGT, NGT, OGTTs, PI
61  2010 Prevalence of dyslipidemia in adults with cystic fibrosis. CF, PI
62  2010 The size of the spleen by magnetic resonance imaging in patients with cystic fibrosis; with and without diabetes--a novel observational study. BMI, CF, HbA1c, MRI, T1DM
63  2009 Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress. CF, CFTR
64  2009 Dichotomy between postprandial glucose and lipid profiles in adults with cystic fibrosis: a pilot study. CF, FFA, NGT, OGTT, TG, TM
65  2009 Increased augmentation index in patients with cystic fibrosis. AIx, CF, CRP, PWV
66  2009 [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis]. CF, CGMS
67  2008 Bilateral sequential lung and simultaneous pancreas transplant: a new approach for the recipient with cystic fibrosis. CF
68  2008 CFTR mutations impart elevated immune reactivity in a murine model of cystic fibrosis related diabetes. CF, LR, SI, STZ
69  2008 Simultaneous bilateral lung and pancreas transplantation in recipient with cystic fibrosis. CF
70  2006 Calpain 10 and development of diabetes mellitus in cystic fibrosis. CF, DM, NGT
71  2006 Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance. BMI, CF, IGT, OGTT
72  2005 Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. CF
73  2005 Effect of nebulized albuterol on blood glucose in patients with diabetes mellitus with and without cystic fibrosis. CF, DM
74  2005 Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis. BMI, CF, FVC
75  2005 Simultaneous liver and pancreas transplantation in patients with cystic fibrosis. CF
76  2003 Management of cystic fibrosis-related diabetes in adolescence. CF
77  2002 Diagnosis, screening, and management of cystic fibrosis-related diabetes. CF
78  2002 Invasive mechanical ventilation for acute respiratory failure in children with cystic fibrosis: outcome analysis and case-control study. ARF, CF, FVC, HEM, IMV, PTX
79  2001 Glucose intolerance in cystic fibrosis patients. CF
80  2001 Mechanisms of insulin resistance in cystic fibrosis. CF, FFA, GDR, IGT, NIH, TNF
81  2000 Cystic fibrosis-related diabetes: an approach to diagnosis and management. CF
82  2000 Pathogenesis of malnutrition in cystic fibrosis, and its treatment. GE, RMR, TDEE
83  1999 Diabetes mellitus in cystic fibrosis. CF
84  1998 Identification and treatment of cystic fibrosis-related diabetes. A survey of current medical practice in the U.S. ATS, CF, IGT, LWPES